A congenitalis adrenalis hyperplasia kezeléséröl.

Translated title of the contribution: Management of congenital adrenal hyperplasia

Research output: Contribution to journalReview article

Abstract

This review deals with the current problems in the management of classical 21-hydroxylase deficiency from the fetal life to the puberty. The clinical consequences of 21-hydroxylase deficiency reflect the disordered physiology--impaired secretion of glucocorticoids and mineralocorticoids, and excessive secretion of androgens. Current therapy is intended to correct the disordered physiology by replacing mineralocorticoid and glucocorticoid hormones, thereby reducing the ACTH-driven increase in adrenal androgen secretion. Treated patients should expect a normal life span and reproductive potential. This can be achieved by careful attention to regular measurements of clinical parameters and biochemical indices of control.

Original languageHungarian
Pages (from-to)1539-1544; 1547
JournalOrvosi hetilap
Volume133
Issue number25
Publication statusPublished - Jun 21 1992

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this